Balance Sheet

Assets

+40%

+113%

10Y

Currency: JPY

	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024
Assets
Cash & Cash Equivalents	36 226	57 380	74 380	68 332	73 167	70 768	106 978	76 212	107 163	95 445	115 070	114 037	101 707	95 368	139 074	146 860	203 941	212 333	267 753	222 169	458 674	540 202
Cash	0	0	0	0	0	0	0	0	0	92 101	110 810	105 435	97 902	91 580	136 219	140 912	195 514	205 734	261 331	215 619	440 517	468 877
Cash Equivalents	36 226	57 380	74 380	68 332	73 167	70 768	106 978	76 212	107 163	3 344	4 260	8 602	3 805	3 788	2 855	5 948	8 427	6 599	6 422	6 550	18 157	71 325
Short-Term Investments	30 694	39 937	68 645	81 894	65 547	54 715	52 157	59 699	60 995	118 185	126 940	117 941	137 828	120 909	106 125	104 737	134 169	166 287	204 217	280 938	280 308	456 143
Total Receivables	113 213	104 029	118 526	105 694	106 959	108 399	121 572	113 386	110 910	128 650	128 387	159 887	158 717	167 483	175 001	179 559	181 641	253 354	356 009	514 283	320 348	335 152
Accounts Receivables	113 213	104 029	118 526	105 694	106 959	108 399	121 572	113 386	110 910	115 993	111 085	141 322	134 450	140 699	148 471	150 778	139 628	195 632	281 319	436 383	252 530	258 335
Other Receivables	0	0	0	0	0	0	0	0	0	12 657	17 302	18 565	24 267	26 784	26 530	28 781	42 013	57 722	74 690	77 900	67 818	76 817
Inventory	53 156	57 916	47 440	61 531	55 186	78 735	92 641	104 884	104 983	108 413	128 536	139 571	161 135	185 440	169 056	159 360	168 122	183 893	208 838	292 206	273 480	240 067
Other Current Assets	22 213	15 672	19 445	20 207	28 945	31 734	37 951	32 353	35 376	4 407	5 302	7 468	8 386	9 560	9 885	9 577	11 807	19 039	26 844	26 941	33 616	34 479
Total Current Assets	255 502	274 934	328 436	337 658	329 804	344 351	411 299	386 534	419 427	455 100	504 235	538 904	567 773	578 760	599 141	600 093	699 680	834 906	1 063 661	1 336 537	1 366 426	1 606 043
PP&E Net	91 969	90 051	79 458	85 150	92 496	98 345	93 662	87 953	82 933	143 056	140 445	140 245	153 545	157 081	171 569	222 388	265 308	297 490	352 107	386 651	420 701	441 554
PP&E Gross	91 969	90 051	79 458	85 150	92 496	98 345	93 662	87 953	82 933	143 056	140 445	140 245	153 545	157 081	171 569	222 388	265 308	297 490	352 107	386 651	420 701	441 554
Accumulated Depreciation	126 435	128 937	127 494	131 797	139 936	151 082	163 560	177 379	176 470	135 248	145 202	152 396	154 253	164 631	176 284	181 566	194 235	209 647	218 950	238 196	203 701	218 405
Intangible Assets	3 373	2 791	6 135	5 131	3 723	3 105	3 243	2 362	1 960	6 500	9 514	11 286	13 511	19 299	21 078	22 699	23 540	23 880	21 974	25 141	19 860	17 868
Note Receivable	192	152	100	88	64	44	32	19	7	0	0	0	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	17 101	13 263	18 482	15 149	16 832	14 387	9 657	7 587	6 431	0	0	0	0	0	0	9 723	2 958	3 029	11 776	11 474	12 505	16 616
Other Long-Term Assets	37 055	30 252	23 820	18 941	16 013	18 279	22 647	23 555	22 716	40 669	43 018	49 103	52 572	51 145	60 685	64 645	67 429	76 193	89 176	109 955	113 055	126 292
Total Assets	405 192 N/A	411 443 +2%	456 431 +11%	462 117 +1%	458 932 -1%	478 511 +4%	540 540 +13%	508 010 -6%	533 474 +5%	645 325 +21%	697 212 +8%	739 538 +6%	787 401 +6%	806 285 +2%	852 473 +6%	919 548 +8%	1 058 915 +15%	1 235 498 +17%	1 538 694 +25%	1 869 758 +22%	1 932 547 +3%	2 208 373 +14%
Liabilities
Accounts Payable	20 709	19 164	20 989	28 134	17 325	28 765	34 263	19 489	17 350	41 797	35 938	35 387	41 174	42 529	38 434	35 934	47 726	58 284	97 203	144 054	54 233	16 147
Accrued Liabilities	18 523	22 549	19 908	17 353	23 531	25 527	32 962	21 554	25 843	26 798	27 173	37 741	37 905	37 178	41 823	48 075	54 831	57 334	65 074	65 674	94 648	88 897
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	11	1 000	0	0	342	0	7	0	0	44	38	29	131	135	129	133	7 263	6 649	6 550	6 434	6 975	6 365
Other Current Liabilities	17 056	20 642	37 565	19 776	28 594	24 228	33 246	13 534	25 625	26 079	34 518	41 193	53 848	43 818	42 516	51 076	69 448	113 803	158 595	207 568	132 361	178 948
Total Current Liabilities	56 299	63 355	78 462	65 263	69 792	78 520	100 478	54 577	68 818	94 718	97 667	114 350	133 058	123 660	122 902	135 218	179 268	236 070	327 422	423 730	288 217	290 357
Long-Term Debt	10 750	5 167	1 348	451	0	0	8	0	0	213	195	185	604	510	207	82	5 489	4 635	9 490	7 675	6 480	4 532
Deferred Income Tax	18	3	2	2	2	1	0	0	104	9 963	12 211	10 722	10 028	9 146	9 211	9 031	9 304	9 166	7 614	7 086	5 787	5 076
Minority Interest	903	1 462	1 692	2 006	2 222	1 651	1 788	1 363	1 208	1 200	1 512	1 657	1 414	989	973	664	0	0	0	0	0	0
Other Liabilities	40 503	20 612	6 621	4 796	3 343	2 925	5 370	4 041	5 482	11 270	13 935	16 525	16 440	26 472	27 256	18 688	10 869	5 624	6 151	6 880	6 483	6 909
Total Liabilities	108 473 N/A	90 599 -16%	88 125 -3%	72 518 -18%	75 359 +4%	83 097 +10%	107 644 +30%	59 981 -44%	75 612 +26%	117 364 +55%	125 520 +7%	143 439 +14%	161 544 +13%	160 777 0%	160 549 0%	163 683 +2%	204 930 +25%	255 495 +25%	350 677 +37%	445 371 +27%	306 967 -31%	306 874 0%
Equity
Common Stock	68 237	70 531	72 443	72 893	72 947	72 966	72 966	72 966	72 966	72 967	72 967	72 967	72 967	72 967	72 970	73 000	73 016	73 202	73 202	73 202	73 202	73 202
Retained Earnings	144 062	164 854	206 834	226 209	248 237	271 334	308 520	328 417	340 491	397 221	426 213	451 220	488 954	507 399	550 974	618 091	722 076	849 093	1 054 050	1 293 352	1 488 738	1 746 934
Additional Paid In Capital	88 099	90 387	92 296	92 747	92 796	92 815	92 815	92 815	92 815	64 668	65 768	67 317	62 567	63 500	64 815	66 043	67 037	67 586	68 223	68 806	69 355	69 896
Unrealized Security Profit/Loss	2 340	2 405	3 781	3 236	2 757	1 354	1 636	1 341	842	1 871	3 704	4 755	6 599	4 864	6 068	4 933	530	400	91	205	162	149
Treasury Stock	5 936	7 616	7 611	7 590	35 108	35 168	36 274	36 256	36 260	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Equity	85	283	561	2 103	1 944	7 889	6 767	11 252	12 992	8 766	3 040	160	5 230	3 222	2 903	6 202	8 674	10 278	7 549	10 768	5 877	11 616
Total Equity	296 717 N/A	320 844 +8%	368 304 +15%	389 598 +6%	383 573 -2%	395 412 +3%	432 896 +9%	448 031 +3%	457 862 +2%	527 961 +15%	571 692 +8%	596 099 +4%	625 857 +5%	645 508 +3%	691 924 +7%	755 865 +9%	853 985 +13%	980 003 +15%	1 188 017 +21%	1 424 387 +20%	1 625 580 +14%	1 901 499 +17%
Total Liabilities & Equity	405 190 N/A	411 443 +2%	456 429 +11%	462 116 +1%	458 932 -1%	478 509 +4%	540 540 +13%	508 012 -6%	533 474 +5%	645 325 +21%	697 212 +8%	739 538 +6%	787 401 +6%	806 285 +2%	852 473 +6%	919 548 +8%	1 058 915 +15%	1 235 498 +17%	1 538 694 +25%	1 869 758 +22%	1 932 547 +3%	2 208 373 +14%
Shares Outstanding
Common Shares Outstanding	1 639	1 649	1 660	1 662	1 634	1 634	1 633	1 633	1 633	1 633	1 634	1 636	1 638	1 639	1 640	1 642	1 643	1 644	1 644	1 645	1 645	1 646

Income Statement Balance Sheet Cash Flow Statement

Chugai Pharmaceutical Co Ltd
TSE:4519

Balance Sheet

Balance Sheet Decomposition
Chugai Pharmaceutical Co Ltd

Balance Sheet
Chugai Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Chugai Pharmaceutical Co Ltd TSE:4519

Balance Sheet

Balance Sheet Decomposition Chugai Pharmaceutical Co Ltd

Balance Sheet Chugai Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Chugai Pharmaceutical Co Ltd
TSE:4519

Balance Sheet Decomposition
Chugai Pharmaceutical Co Ltd

Balance Sheet
Chugai Pharmaceutical Co Ltd